Mayo Clinic at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
Mayo Clinic takes part in 6 sessions at CTAD 2026 in Boston. Its program centres on blood biomarkers and population studies of cognitive ageing. Its work covers the Lumipulse plasma p-tau217 assays in cognitively unimpaired people, kidney disease effects on biomarker levels and a web-based registry for dementia research.
| Organization | CTAD 2026 Attendance |
|---|---|
Mayo Clinic Rochester, Minnesota | |
Academic medical centre in Minnesota, Arizona and Florida; runs the Mayo Clinic Study of Aging and an Alzheimer's Disease Research Center. | Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Poster Wed Nov 18 7:15am–5:30pm Poster Wed Nov 18 7:15am–5:30pm Poster Thu Nov 19 7:15am–5:00pm |
Instantly find 20 buyers from Mayo Clinic
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction